Lack of association between peroxisome proliferator-activated receptor-γ-2 gene variants and the occurrence of coronary heart disease in patients with diabetes mellitus

European Journal of Endocrinology

Volumn 146, Issue 4, 2002, Pages 545-551

  Bluher M ^a   Klemm, T ^a   Gerike, T ^a   Krankenberg, H ^a   Schuler, G ^a   Paschke, R ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; GLYCINE; HEMOGLOBIN A1C; LEUCINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METHIONINE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROLINE; VALINE;

ADULT; AGE; AGED; ARTICLE; BODY MASS; CIGARETTE SMOKING; CONTROLLED STUDY; DENATURING GRADIENT GEL ELECTROPHORESIS; DISEASE ASSOCIATION; FEMALE; GENDER; GENE MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR;

EID: 0036225273     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1460545     Document Type: Article

References (39)

1. Peroxisome proliferator-activated receptors, orphans with ligands and functions
2. CLA-1/SR-BI is expressed in atherosclerotic lesion macrophages and regulated by activators of peroxisome proliferator-activated receptors
3. Differential expression of peroxisome proliferator-activated receptors: Tissue distribution of PPAR α, β, and γ in the adult rat
4. The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation
5. PPAR γ promotes monocyte/macrophage differentiation and uptake of oxidized LDL
6. Peroxisome proliferator-activated receptor γ ligands and atherosclerosis: Ending the heartache
7. Activation of peroxisome proliferator-activated receptors α and γ induces apoptosis of human monocyte-derived macrophages
8. Roles of PPARs in health and disease
9. The peroxisome proliferator-activated receptor (PPARgamma) as a regulator of monocyte/macrophage function
10. Macrophages in human atheroma contain PPARgamma: Differentiation-dependent peroxisomal proliferator-activated receptor gamma (PPARgamma) expression and reduction of MMP-9 activity through phagocytes in vitro
11. Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma
12. The role of PPAR-gamma in macrophage differentiation and cholesterol uptake
13. PPAR gamma- LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis
14. PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation
15. PPAR-γ agonists inhibit production of monocyte inflammation cytokines
16. Peroxisome proliferator-activated receptor ligands inhibit development of atherosclerosis in LDL receptor-deficient mice
17. Oxidized low-density lipoprotein and peroxisome-proliferator-activated receptor alpha down-regulate platelet-activating-factor receptor expression in human macrophages
18. Potent inhibitory effect of troglitazone on carotid arterial wall thickness in type 2 diabetes
19. Peroxisome proliferator-activated receptor gamma C161T polymorphism and coronary artery disease
20. Dominant negative mutations in human PPARγ associated with severe insulin resistance, diabetes mellitus and hypertension
21. Human obesity associated with a mutation in PPARγ2, a regulator of adipocyte differentiation
22. Molecular scanning of the human peroxisome proliferator-activated receptor-γ (PPAR-γ) gene in diabetic Caucasians: Identification of a Pro12Ala PPARγ2 missense mutation
23. DGGE is more sensitive for the detection of somatic point mutations than direct sequencing
24. Vascular thrombosis in type II diabetes mellitus
25. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction
26. Mortality and survival in type 2 (non insulin dependent) diabetes mellitus
27. PPARγ activation in human endothelial cells increases plasminogen activator inhibitor type-1 expression
28. Activation of human aortic smooth-muscle cells is inhibited by PPARγ but not by PPARγ activators
29. Expression of the peroxisome proliferator-activated receptor-γ (PPAR-γ) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein
30. Troglitazone reduces neointimal tissue proliferation after coronary stent implantation in patients with non-insulin dependent diabetes mellitus: A serial intravascular ultrasound study
31. Homozygosity of the Pro12Ala variant of the peroxisome proliferator-activated receptor-γ2 (PPAR-γ2): Divergent modulating effects on body mass index in obese and lean Caucasian men
32. Missense variants in the human peroxisome proliferator-activated receptor-γ2 gene in lean and obese subjects
33. Pro115Gln peroxisome proliferator-activated receptor-γ and obesity
34. Pro12Ala substitution in PPARγ2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity
35. Association of the Pro12Ala variant in the peroxisome proliferator-activated receptor-γ2 gene with obesity in two Caucasian populations
36. Two polymorphisms in the peroxisome proliferator-activated receptor-γ gene are associated with severe overweight among obese women
37. The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes
38. Effect of the Pro12Ala variant of the human peroxisome proliferator-activated receptor-γ2 gene on adiposity, fat distribution, and insulin sensitivity in Japanese men